1. Home
  2. AGIO vs CLBK Comparison

AGIO vs CLBK Comparison

Compare AGIO & CLBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$37.57

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Columbia Financial Inc.

CLBK

Columbia Financial Inc.

HOLD

Current Price

$10.85

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
CLBK
Founded
2007
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.2B
IPO Year
2013
2026

Fundamental Metrics

Financial Performance
Metric
AGIO
CLBK
Price
$37.57
$10.85
Analyst Decision
Buy
Hold
Analyst Count
8
1
Target Price
$38.88
$17.00
AVG Volume (30 Days)
1.0M
6.0M
Earning Date
04-29-2026
04-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,011,000.00
N/A
Revenue This Year
$76.75
$3.97
Revenue Next Year
$170.73
$11.43
P/E Ratio
N/A
$83.69
Revenue Growth
N/A
N/A
52 Week Low
$22.24
$10.70
52 Week High
$46.00
$25.83

Technical Indicators

Market Signals
Indicator
AGIO
CLBK
Relative Strength Index (RSI) 52.01 21.05
Support Level $26.71 N/A
Resistance Level $44.01 $16.53
Average True Range (ATR) 1.69 0.71
MACD -0.77 -1.35
Stochastic Oscillator 27.89 0.89

Price Performance

Historical Comparison
AGIO
CLBK

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

About CLBK Columbia Financial Inc.

Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a customer service-focused institution. The company offers traditional financial services to businesses and consumers in its market areas. It attracts deposits from the general public and uses those funds to originate various loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans. The company also offers title insurance through its wholly owned subsidiary and provides a broad range of insurance products, including personal and business lines of insurance, mainly to customers and New Jersey residents.

Share on Social Networks: